Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Aust N Z J Obstet Gynaecol ; 51(3): 210-5, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21631438

RESUMO

BACKGROUND: There appears to be a rise in the rate of emergency peripartum hysterectomy (EPH) in the developed world. AIMS: To determine the incidence, indications, risk factors, complications and management of EPH in our tertiary level teaching hospital, the Royal Hospital for Women (RHW) in Sydney, over the last decade. METHODS: A retrospective analysis was conducted of all cases of EPH performed at the RHW between the years 1999-2008 inclusive. EPH was defined as one performed after 20 weeks gestation for uncontrollable uterine bleeding not responsive to conservative measures occurring at any time after delivery but within the first 6 weeks post-partum. Cases were ascertained via our hospital obstetric database. RESULTS: There were 33 EPH among 38,998 births, a rate of 0.85 per 1000 births. Indications for EPH were morbid adherence of the placenta (54.8%), placenta praevia (19.4%), uterine atony (12.9%) and uterine rupture or cervical laceration (9.7%). A significant association between previous caesarean section (CS) and abnormal placentation was confirmed (P=0.011), especially for morbid adherence of the placenta (P=0.004). There was one maternal death. Maternal morbidity was significant, with disseminated intravascular coagulation and urinary tract injury among the most common complications. All women required blood transfusions, and over a quarter were admitted to the intensive care unit. CONCLUSIONS: In our series, abnormal placentation causing severe haemorrhage was the commonest indication for EPH. Previous CS is a risk factor for abnormal placentation and particularly for morbid adherence of the placenta. The morbidity associated with EPH is considerable.


Assuntos
Histerectomia/estatística & dados numéricos , Período Periparto , Adulto , Transfusão de Sangue , Cesárea/estatística & dados numéricos , Coagulação Intravascular Disseminada/epidemiologia , Emergências/epidemiologia , Feminino , Hospitais de Ensino , Humanos , Incidência , Mortalidade Materna , Placenta Prévia/epidemiologia , Placenta Prévia/cirurgia , Hemorragia Pós-Parto/epidemiologia , Hemorragia Pós-Parto/cirurgia , Gravidez , Complicações Hematológicas na Gravidez/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Sistema Urinário/lesões , Hemorragia Uterina/epidemiologia , Hemorragia Uterina/cirurgia , Inércia Uterina/epidemiologia , Inércia Uterina/cirurgia , Ruptura Uterina/epidemiologia , Ruptura Uterina/cirurgia
2.
ANZ J Surg ; 86(5): 386-90, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-24846566

RESUMO

BACKGROUND: Gastric cancer is one of the leading causes of cancer-related deaths worldwide. Large Western trials have shown overall 5-year survival rates of 36-47%. Surgical resection remains the mainstay of curative treatment. We report the outcomes at a single Australian centre. METHODS: We analysed a prospectively kept database of patients after gastric resection for adenocarcinoma at a tertiary Australian hospital. Disease-specific survival (DSS) was considered the primary end-point. RESULTS: One hundred and seventy-three patients underwent gastrectomy with curative intent. Average age at diagnosis was 68, with 72% being male patients. One hundred patients had a total gastrectomy and 73 had subtotal. The average number of lymph nodes examined was 23. All patients were discussed in a multidisciplinary setting. Perioperative morbidity rate was 31%, with 3.5% 30-day mortality. Five-year DSS was 67.4% with 91.2%, 76.7% and 39.3% for stage 1, 2 and 3 disease, respectively. Five-year overall survival considering death from any cause was 47.4%. CONCLUSION: This large Australian single centre study shows outcomes equivalent to other Western series and approaches that of Japanese data. High survival figures can be achieved when gastrectomy is performed by an experienced institution through a multi-modality approach with adequate staging, aggressive and appropriate resection and selective use of perioperative therapy.


Assuntos
Adenocarcinoma/terapia , Estadiamento de Neoplasias , Neoplasias Gástricas/terapia , Adenocarcinoma/diagnóstico , Adenocarcinoma/epidemiologia , Terapia Combinada , Feminino , Seguimentos , Humanos , Masculino , Morbidade/tendências , New South Wales/epidemiologia , Prognóstico , Estudos Retrospectivos , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/epidemiologia , Taxa de Sobrevida/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA